Total Clarity Wealth Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-500
Closed -$6K 1041
2022
Q2
$6K Buy
+500
New +$5.52K ﹤0.01% 797
2022
Q1
Sell
-500
Closed -$8K 985
2021
Q4
$8K Sell
500
-350
-41% -$6.68K ﹤0.01% 744
2021
Q3
$19K Buy
+850
New +$18.7K 0.01% 572
2021
Q2
Sell
-350
Closed -$7K 808
2021
Q1
$7K Buy
+350
New +$7.97K ﹤0.01% 638

Other funds holding MYOV

Total Clarity Wealth Management's MYOV Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 500 shares — an estimated $6K sold.

Total Clarity Wealth Management first reported a position in MYOV in Q1 2021 and held it in 4 quarters. The position peaked at $19K in Q3 2021. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 500 Myovant Sciences Ltd. shares in Q3 2022, an estimated $6K.
  • Total Clarity Wealth Management first reported a position in Myovant Sciences Ltd. in Q1 2021 and held it in 4 quarters.
  • Total Clarity Wealth Management's Myovant Sciences Ltd. position peaked at $19K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.